Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells.
Shikonin, a small-molecule natural product which inhibits the activity of pyruvate kinase M2 (PKM2), has been studied as an anti-cancer drug candidate in human cancer models. Here, our results demonstrate that shikonin is able to sensitize human breast cancer cells to chemotherapy by paclitaxel (tax...
Saved in:
| Main Authors: | Wenjuan Li, Joan Liu, Kasey Jackson, Runhua Shi, Yunfeng Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094079&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An oxidative stress mechanism of shikonin in human glioma cells.
by: Jen-Tsung Yang, et al.
Published: (2014-01-01) -
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer
by: Ozlem Yedier-Bayram, et al.
Published: (2025-06-01) -
Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective
by: Pratibha Pandey, et al.
Published: (2025-07-01) -
Shikonin Induces Autophagy and Apoptosis in Esophageal Cancer EC9706 Cells by Regulating the AMPK/mTOR/ULK Axis
by: Junli Zhang, et al.
Published: (2024-01-01) -
COMBINATION OF TAXOL WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH STAGES IIB-IV OVARIAN CANCER (FIRST MULTI-CENTER EXPERIENCE IN RUSSIA)
by: Zh. A. Martinova, et al.
Published: (2014-09-01)